Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jul 11 2021

Toxoplasmosis (CNS)

  • Snapshot
    • A 29-year-old male is brought to the emergency department by his male partner due to chronic headache and confusion. The patient is HIV positive, and his CD4+ count one month ago was 73 cells/μL. He has not been adherent to his antiretroviral and prophylactic therapy. An MRI of the head is shown. Enzyme linked immunoassay (ELISA) shows positive anti-toxoplasma IgG antibodies.
  • Introduction
    • Most common infection of the central nervous system in patients with AIDS
    • Caused by Toxoplasma gondii
      • an obligate intracellular protozoan
    • Infection in immunocompetent
      • usually asymptomatic
    • Infection in immunosuppressed (e.g., AIDS)
      • parasite reactivation → infection
      • CD4+ count < 100 cells/μL
      • encephalitis
        • ring-enhancing lesion on head imaging
      • retinochoroiditis
    • Extracerebral manifestations of toxoplasmosis
      • choroiretinitis
      • pneumonitis
  • Epidemiology
    • 30% risk of reactivation in immunocompromised (especially CD4+ count < 100 cells/μL)
      • in those not receiving prophylaxis or antiretroviral therapy
    • ~ 30% of the worldwide population is infected
  • Presentation
    • Symptoms
      • headache
      • fever
      • seizure
      • focal neurological deficit
      • confusion
      • flu-like symptoms
    • Physical symptoms
      • cervical lymphadenopathy
  • Evaluation
    • Head imaging
      • Head CT or head MRI
        • ring-enhancing lesion
        • MRI is more sensitive and preferred
    • Serology
      • testing for anti-toxoplasma IgM and IgG antibodies via ELISA
  • Differential
    • Brain abscess
    • CNS lymphoma
    • Metastatic cancer
    • Neurocysticercosis
  • Treatment
    • Medical
      • pyrimethamine + sulfadiazine + leucovorin
        • can replace sulfadiazine with clindamycin in those intolerant to sulfa-drugs
      • corticosteroids
        • only in those with mass effect
      • anticonvulsants
        • only in those presenting with seizures
    • Special considerations
      • HIV
        • CD4+ Count < 100 mm3
          • for patients with a past medical history of HIV with severe immunosuppression (CD4 <100 cells/µL), focal neurologic findings, and ring-enhancing lesions on head imaging, the next step in management is empiric treatment for toxoplasma encephalitis with pyrimethamine-sulfadiazine for 10-14 days.
            • get follow-up head imaging after 10-14 days. If the patient fails to improve clinically or the size of the lesion does not change, the next step would be a biopsy of the lesion.
  • Prevention, Prognosis, and Complications
    • Prevention
      • primary prophylaxis with TMP-SMX in those with a CD4+ count < 100 cells/μL
        • alternative
          • atovaquone +/- pyrimethamine (+ leucovorine)
          • dapsone + pyrimethamine + leucovorine
      • safe water use
      • frequently change the cat litter
      • thoroughly clean fruits, vegetables, and meats
      • don't drink unpasteurized goat milk
    • Prognosis
      • severe in immunocompromised
        • ↑ mortality
    • Complications
      • maternal transmission
      • reactivation mostly occurs in the immunocompromised
1 of 0
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options